Filing Details
- Accession Number:
- 0001493152-20-013735
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-21 19:28:33
- Reporting Period:
- 2020-07-13
- Accepted Time:
- 2020-07-21 19:28:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1382574 | Trxade Group Inc. | MEDS | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1617460 | Prashant Patel | 3840 Land O'Lakes Blvd Land O'Lakes FL 34639 | President | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-07-13 | 500 | $5.71 | 1,274,500 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-14 | 7,000 | $5.44 | 1,267,500 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 400,000 | Indirect | Through Patel Trust 2010 which Reporting Person controls as trustee |
Common Stock | 416,667 | Indirect | Through spouse |
Footnotes
- The shares were sold pursuant to a 10b5-1 trading plan previously adopted by the Reporting Person to satisfy the Reporting Person's tax liability in connection with the April 2020 grant of certain restricted stock which were granted under the Company's 2019 Equity Incentive Plan, which award was exempt from Section 16(b) pursuant to Rule 16b-3(b).
- Represents the weighted sales price for all sales made on July 14, 2020, which were made in a range of between ($5.31) and ($5.55) per share. The Reporting Person will provide to the Commission, the Issuer or any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.